FDA Import Refusal FP1-0021181-1/41/1 — KENT PHARMACEUTICALS
The FDA refused shipment FP1-0021181-1/41/1 from KENT PHARMACEUTICALS (United Kingdom) on Feb 26, 2018. The refused product falls under Drugs and Biologics — DOXYCYCLINE HYCLATE (TETRACYCLINES). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 26, 2018
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 56ECE22 DOXYCYCLINE HYCLATE (TETRACYCLINES)
- Charges
- 118,3280,75